Pancreatic Ductal Adenocarcinoma Clinical Trials

ReadTheTrial indexes 2 studies for Pancreatic Ductal Adenocarcinoma. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Pancreatic Ductal Adenocarcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials for Pancreatic Ductal Adenocarcinoma

A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients With Advanced KRAS G12D-Mutated Solid Tumors

NCT07020221 · RECRUITING · Phase 2

Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

NCT06562192 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Pancreatic Ductal Adenocarcinoma?

There are 2 clinical trials listed for Pancreatic Ductal Adenocarcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Pancreatic Ductal Adenocarcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Pancreatic Ductal Adenocarcinoma trials in?

Current Pancreatic Ductal Adenocarcinoma trials are distributed across: Phase 2 (1), Phase 1 (1).

Find More Trials